The impact of array genomic hybridization on mental retardation research: A review of current technologies and their clinical utility

Farah Zahir, J. M. Friedman

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Our understanding of the causes of mental retardation is benefiting greatly from whole-genome scans to detect submicroscopic pathogenic copy number variants (CNVs) that are undetectable by conventional cytogenetic analysis. The current method of choice for performing whole-genome scans for CNVs is array genomic hybridization (AGH). Several platforms are available for AGH, each with its own strengths and limitations. This review discusses considerations that are relevant to the clinical use of whole-genome AGH platforms for the diagnosis of pathogenic CNVs in children with mental retardation. Whole-genome AGH studies are a maturing technology, but their high diagnostic utility assures their increasing use in clinical genetics.

Original languageEnglish
Pages (from-to)271-287
Number of pages17
JournalClinical Genetics
Volume72
Issue number4
DOIs
Publication statusPublished - Oct 2007
Externally publishedYes

Fingerprint

Nucleic Acid Hybridization
Intellectual Disability
Genome
Technology
Research
Cytogenetic Analysis

Keywords

  • Array genomic hybridization
  • Comparative genomic hybridization
  • Copy Number Variant Diagnostics
  • Mental retardation

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

The impact of array genomic hybridization on mental retardation research : A review of current technologies and their clinical utility. / Zahir, Farah; Friedman, J. M.

In: Clinical Genetics, Vol. 72, No. 4, 10.2007, p. 271-287.

Research output: Contribution to journalReview article

@article{b42e7c896585491fbb4e16b0006a928e,
title = "The impact of array genomic hybridization on mental retardation research: A review of current technologies and their clinical utility",
abstract = "Our understanding of the causes of mental retardation is benefiting greatly from whole-genome scans to detect submicroscopic pathogenic copy number variants (CNVs) that are undetectable by conventional cytogenetic analysis. The current method of choice for performing whole-genome scans for CNVs is array genomic hybridization (AGH). Several platforms are available for AGH, each with its own strengths and limitations. This review discusses considerations that are relevant to the clinical use of whole-genome AGH platforms for the diagnosis of pathogenic CNVs in children with mental retardation. Whole-genome AGH studies are a maturing technology, but their high diagnostic utility assures their increasing use in clinical genetics.",
keywords = "Array genomic hybridization, Comparative genomic hybridization, Copy Number Variant Diagnostics, Mental retardation",
author = "Farah Zahir and Friedman, {J. M.}",
year = "2007",
month = "10",
doi = "10.1111/j.1399-0004.2007.00847.x",
language = "English",
volume = "72",
pages = "271--287",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The impact of array genomic hybridization on mental retardation research

T2 - A review of current technologies and their clinical utility

AU - Zahir, Farah

AU - Friedman, J. M.

PY - 2007/10

Y1 - 2007/10

N2 - Our understanding of the causes of mental retardation is benefiting greatly from whole-genome scans to detect submicroscopic pathogenic copy number variants (CNVs) that are undetectable by conventional cytogenetic analysis. The current method of choice for performing whole-genome scans for CNVs is array genomic hybridization (AGH). Several platforms are available for AGH, each with its own strengths and limitations. This review discusses considerations that are relevant to the clinical use of whole-genome AGH platforms for the diagnosis of pathogenic CNVs in children with mental retardation. Whole-genome AGH studies are a maturing technology, but their high diagnostic utility assures their increasing use in clinical genetics.

AB - Our understanding of the causes of mental retardation is benefiting greatly from whole-genome scans to detect submicroscopic pathogenic copy number variants (CNVs) that are undetectable by conventional cytogenetic analysis. The current method of choice for performing whole-genome scans for CNVs is array genomic hybridization (AGH). Several platforms are available for AGH, each with its own strengths and limitations. This review discusses considerations that are relevant to the clinical use of whole-genome AGH platforms for the diagnosis of pathogenic CNVs in children with mental retardation. Whole-genome AGH studies are a maturing technology, but their high diagnostic utility assures their increasing use in clinical genetics.

KW - Array genomic hybridization

KW - Comparative genomic hybridization

KW - Copy Number Variant Diagnostics

KW - Mental retardation

UR - http://www.scopus.com/inward/record.url?scp=34548572847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548572847&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2007.00847.x

DO - 10.1111/j.1399-0004.2007.00847.x

M3 - Review article

C2 - 17850622

AN - SCOPUS:34548572847

VL - 72

SP - 271

EP - 287

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 4

ER -